Condition
Total Body Irradiation
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 2 (1)
P 3 (2)
Trial Status
Completed2
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07709195Phase 2Recruiting
Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant
NCT06673459Phase 3Not Yet Recruiting
BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients
NCT02670252Phase 3Completed
BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT
NCT03123133CompletedPrimary
Gene Expression That Predicts Radiation Exposure in Humans
Showing all 4 trials